ストックスクリーナーアプリを入手
0.2027
1.35%
0.0027
アフターアワーズ：
.20
-0.0027
-1.33%
前日終値:
$0.20
開ける：
$0.2019
24時間の取引高:
682.57K
Relative Volume:
0.32
時価総額：
$27.48M
収益：
$1.47M
当期純損益:
$-23.06M
株価収益率:
-0.8914
EPS:
-0.2274
ネットキャッシュフロー:
$-19.64M
1週間 パフォーマンス:
+0.30%
1か月 パフォーマンス:
-9.55%
6か月 パフォーマンス:
-67.70%
1年 パフォーマンス:
-65.64%
1日の値動き範囲:
$0.1979
$0.207
1週間の範囲:
$0.1923
$0.2148
52週間の値動き範囲:
$0.17
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
名前
VolitionRX Ltd
セクター
電話
646 650 1351
住所
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.2027 | 27.11M | 1.47M | -23.06M | -19.64M | -0.2274 |
|
TMO
Thermo Fisher Scientific Inc
|
495.72 | 185.77B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.06 | 138.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
600.52 | 47.68B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
115.42 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
297.54 | 29.39B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 開始されました | Maxim Group | Buy |
| 2018-05-14 | 繰り返されました | The Benchmark Company | Buy |
| 2016-09-07 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-02-01 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
VolitionRX Ltd (VNRX) 最新ニュース
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems - Yahoo Finance
VolitionRx (VNRX) Completes Key Phase for Nu.Q Vet Cancer Test i - GuruFocus
Volition announces first ever automated Nu.Q® Vet cancer test with Fujifilm Vet Systems - marketscreener.com
Automated cancer screening test set for Japan’s 7M pet dogs - Stock Titan
Tax withholding on VolitionRx (VNRX) shares for officer via RSU settlement - Stock Titan
VolitionRx (VNRX) CCO covers tax bill via 2,283-share cancellation - Stock Titan
Tax withholding trims VolitionRx (VNRX) GC Nicholas Plummer’s shares - Stock Titan
VNRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
VolitionRx issues shares to satisfy debt obligations and completes private placement - Investing.com
VNRX SEC FilingsVolitionrx 10-K, 10-Q, 8-K Forms - Stock Titan
VolitionRx (VNRX) grants CCO 149,000 RSUs in lieu of cash pay - Stock Titan
Ethel Rubin receives 178,000 RSU award at VolitionRx Ltd (VNRX) - Stock Titan
Executive at VolitionRx (VNRX) awarded 142,000 RSUs in lieu of cash pay - Stock Titan
VOLITIONRX (VNRX) CFO awarded 202,000 RSUs in lieu of cash pay - Stock Titan
119,000 RSUs granted to VolitionRx (VNRX) secretary in lieu of cash pay - Stock Titan
VolitionRx (VNRX) grants 187,000 RSUs to General Counsel Plummer - Stock Titan
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRx (VNRX) executive receives 173,000 RSUs instead of cash pay - Stock Titan
VolitionRx (VNRX) grants CSO 149,000 RSUs instead of cash - Stock Titan
Director at VolitionRx (VNRX) granted 178,000 RSUs in lieu of cash - Stock Titan
VolitionRx advances cancer tests, expects French reimbursement By Investing.com - Investing.com India
VolitionRx Reports Clinical and Commercial Progress Across Cancer Detection and Sepsis Monitoring Platforms - citybuzz -
VolitionRx advances cancer tests, expects French reimbursement - Investing.com
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution - Yahoo Finance
VolitionRx issues shares to satisfy debt and completes private placement - Investing.com South Africa
VolitionRx (NYSE: VNRX) issues shares to repay Lind note - Stock Titan
VolitionRx issues shares to satisfy debt and completes private placement By Investing.com - Investing.com Canada
Q3 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus
Should You Buy VolitionRX Ltd (VNRX) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Armistice Capital reports 4.99% stake in VolitionRx (VNRX) — 6.45M shares - Stock Titan
Guidance Update: Is VolitionRx Limited gaining market share2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Volume Summary: Is now the right time to enter VolitionRx LimitedJuly 2025 Retail & Step-by-Step Trade Execution Guides - mfd.ru
VolitionRx nears 100 Nu.Q Discover clients, extends reach to Japan - Stock Titan
VolitionRx receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
VolitionRx (VNRX) Plans to Offer Nearly 18 Million Shares - GuruFocus
VolitionRx (VNRX) Faces NYSE American Compliance Challenge - GuruFocus
VolitionRx Gets NYSE American Non-Compliance Notice for Failing Equity Requirements - marketscreener.com
VolitionRx Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VolitionRx stock gets 'below compliance' tag after NYSE warning - Stock Titan
Volume Report: Is VolitionRx Limited affected by consumer sentimentJuly 2025 Earnings & Intraday High Probability Setup Alerts - baoquankhu1.vn
VolitionRx Prepares French Reimbursement Submission for Nu.Q Cancer Blood Tests - MEXC
VolitionRx (VNRX) Moves Forward with French Reimbursement Submis - GuruFocus
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays - Yahoo Finance
What is the cash position of VolitionRx LimitedWeekly Market Report & High Conviction Investment Ideas - mfd.ru
Aug Wrap: Is VolitionRx Limited benefiting from innovation trendsMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
VNRX: D. Boral Capital Maintains Buy Rating and $3 Price Target - GuruFocus
VolitionRx (VNRX) Expands Nu.Q Vet Cancer Test Reach in U.S. and Asia - GuruFocus
Dog cancer blood test expands to all 50 states and parts of Asia - Stock Titan
VolitionRX (VNRX) Receives Buy Rating, Price Target Maintained a - GuruFocus
Why VolitionRx Limited stock is popular among millennialsEarnings Growth Report & Expert Curated Trade Setups - Улправда
VolitionRx Signs Amended Securities Purchase Agreement With Lind Global Asset Management XII - TradingView — Track All Markets
VolitionRX Ltd (VNRX) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
0.64%
大文字化:
|
ボリューム (24 時間):